These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35092722)

  • 41. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Broch K; Anstensrud AK; Woxholt S; Sharma K; Tøllefsen IM; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Bendz C; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
    J Am Coll Cardiol; 2021 Apr; 77(15):1845-1855. PubMed ID: 33858620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction": study protocol for a randomized controlled trial.
    von Lewinski D; Selvanayagam JB; Schatz RA; Jilma B; Kubica J; Povsic TJ; Nix D; Henauer S; Wallner M;
    Trials; 2020 Aug; 21(1):744. PubMed ID: 32843081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.
    Tuñón J; González-Hernández I; Llanos-Jiménez L; Alonso-Martín J; Escudier-Villa JM; Tarín N; Cristóbal C; Sanz P; Pello AM; Aceña Á; Carda R; Orejas M; Tomás M; Beltrán P; Calero Rueda M; Marcos E; Serrano-Antolín JM; Gutiérrez-Landaluce C; Jiménez R; Cabezudo J; Curcio A; Peces-Barba G; González-Parra E; Muñoz-Siscart R; González-Casaus ML; Lorenzo A; Huelmos A; Goicolea J; Ibáñez B; Hernández G; Alonso-Pulpón LM; Farré J; Lorenzo Ó; Mahíllo-Fernández I; Egido J
    BMJ Open; 2016 Aug; 6(8):e011287. PubMed ID: 27496232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction.
    Ibanez B; Fuster V; Macaya C; Sánchez-Brunete V; Pizarro G; López-Romero P; Mateos A; Jiménez-Borreguero J; Fernández-Ortiz A; Sanz G; Fernández-Friera L; Corral E; Barreiro MV; Ruiz-Mateos B; Goicolea J; Hernández-Antolín R; Acebal C; García-Rubira JC; Albarrán A; Zamorano JL; Casado I; Valenciano J; Fernández-Vázquez F; de la Torre JM; Pérez de Prado A; Iglesias-Vázquez JA; Martínez-Tenorio P; Iñiguez A
    Am Heart J; 2012 Oct; 164(4):473-480.e5. PubMed ID: 23067904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI).
    Siddiqi N; Neil C; Bruce M; MacLennan G; Cotton S; Papadopoulou S; Feelisch M; Bunce N; Lim PO; Hildick-Smith D; Horowitz J; Madhani M; Boon N; Dawson D; Kaski JC; Frenneaux M;
    Eur Heart J; 2014 May; 35(19):1255-62. PubMed ID: 24639423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
    Post S; Post MC; van den Branden BJ; Eefting FD; Goumans MJ; Stella PR; van Es HW; Wildbergh TX; Rensing BJ; Doevendans PA
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):756-65. PubMed ID: 22419603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction　- Relationship With Infarct Size, Adverse Remodeling, and Events at 1 Year.
    Cuenin L; Lamoureux S; Schaaf M; Bochaton T; Monassier JP; Claeys MJ; Rioufol G; Finet G; Garcia-Dorado D; Angoulvant D; Elbaz M; Delarche N; Coste P; Metge M; Perret T; Motreff P; Bonnefoy-Cudraz E; Vanzetto G; Morel O; Boussaha I; Ovize M; Mewton N
    Circ J; 2018 Apr; 82(5):1379-1386. PubMed ID: 28943533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.
    Nazir SA; Khan JN; Mahmoud IZ; Greenwood JP; Blackman DJ; Kunadian V; Been M; Abrams KR; Wilcox R; Adgey AA; McCann GP; Gershlick AH
    Trials; 2014 Sep; 15():371. PubMed ID: 25252600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
    Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S
    Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Yan Y; Wang X; Guo J; Li Y; Ai H; Gong W; Que B; Zhen L; Lu J; Ma C; Montalescot G; Nie S
    Am Heart J; 2020 Sep; 227():19-30. PubMed ID: 32663660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study.
    Steg P; Lopez-de-Sà E; Schiele F; Hamon M; Meinertz T; Goicolea J; Werdan K; Lopez-Sendon JL;
    Eur Heart J Acute Cardiovasc Care; 2013 Sep; 2(3):270-9. PubMed ID: 24222839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial).
    Dominguez-Rodriguez A; Abreu-Gonzalez P; de la Torre-Hernandez JM; Consuegra-Sanchez L; Piccolo R; Gonzalez-Gonzalez J; Garcia-Camarero T; Del Mar Garcia-Saiz M; Aldea-Perona A; Reiter RJ;
    Am J Cardiol; 2017 Aug; 120(4):522-526. PubMed ID: 28645475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial.
    Rao SV; Zeymer U; Douglas PS; Al-Khalidi H; Liu J; Gibson CM; Harrison RW; Joseph DS; Heyrman R; Krucoff MW
    Am Heart J; 2015 Nov; 170(5):929-37. PubMed ID: 26542501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
    Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI).
    García Del Blanco B; Otaegui I; Rodríguez-Palomares JF; Bayés-Genis A; Fernández-Nofrerías E; Vilalta Del Olmo V; Carrillo X; Ibáñez B; Worner F; Casanova J; Pueo E; González-Juanatey JR; López-Pais J; Bardají A; Bonet G; Fuertes M; Rodríguez-Sinovas A; Ruiz-Meana M; Inserte J; Barba I; Gómez-Talavera S; Martí G; Serra B; Bellera N; Ojeda-Ramos M; Cuellar H; Valente F; Carmona MÁ; Miró-Casas E; Marsal JR; Sambola A; Lidón RM; Bañeras J; Elízaga J; Padilla F; Barrabés JA; Hausenloy DJ; Ferreira-González I; García-Dorado D
    Basic Res Cardiol; 2021 Jan; 116(1):4. PubMed ID: 33495853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; de la Torre-Hernandez JM; Gonzalez-Gonzalez J; Garcia-Camarero T; Consuegra-Sanchez L; Garcia-Saiz MD; Aldea-Perona A; Virgos-Aller T; Azpeitia A; Reiter RJ;
    J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27736028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome.
    Gibson CM; Mega JL; Burton P; Goto S; Verheugt F; Bode C; Plotnikov A; Sun X; Cook-Bruns N; Braunwald E
    Am Heart J; 2011 May; 161(5):815-821.e6. PubMed ID: 21570509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Zhao DX; Ellis SG; Forder JR; Anderson RD; Hatzopoulos AK; Penn MS; Perin EC; Chambers J; Baran KW; Raveendran G; Lambert C; Lerman A; Simon DI; Vaughan DE; Lai D; Gee AP; Taylor DA; Cogle CR; Thomas JD; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Kappenman C; Westbrook L; Piller LB; Simpson LM; Baraniuk S; Loghin C; Aguilar D; Richman S; Zierold C; Spoon DB; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Dec; 308(22):2380-9. PubMed ID: 23129008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global longitudinal strain by feature tracking for optimized prediction of adverse remodeling after ST-elevation myocardial infarction.
    Reindl M; Tiller C; Holzknecht M; Lechner I; Eisner D; Riepl L; Pamminger M; Henninger B; Mayr A; Schwaiger JP; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Clin Res Cardiol; 2021 Jan; 110(1):61-71. PubMed ID: 32296969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.